98 related articles for article (PubMed ID: 19003707)
21. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
22. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
23. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview.
Scosyrev E; Messing J; Noyes K; Veazie P; Messing E
Urol Oncol; 2012; 30(2):126-32. PubMed ID: 20363162
[TBL] [Abstract][Full Text] [Related]
24. Research participation: are we subject to a duty?
Wachbroit R; Wasserman D
Am J Bioeth; 2005; 5(1):48-9; author reply W15-8. PubMed ID: 16036661
[No Abstract] [Full Text] [Related]
25. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
[TBL] [Abstract][Full Text] [Related]
26. [Breast cancer risk with hormone replacement therapy. A matter of interpretation].
Röhm W
MMW Fortschr Med; 2004 Feb; 146(6):15; author reply 15. PubMed ID: 15035307
[No Abstract] [Full Text] [Related]
27. Striking the right balance in research ethics and regulation.
Miller FG
Am J Bioeth; 2010 Aug; 10(8):65. PubMed ID: 20694916
[No Abstract] [Full Text] [Related]
28. Press statement. Breast cancer and hormone therapy: a looking-glass mirror?
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2007 Oct; 10(5):356-7. PubMed ID: 17852137
[No Abstract] [Full Text] [Related]
29. Decline in breast cancer incidence--United States, 1999-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
[TBL] [Abstract][Full Text] [Related]
30. The surveillance, epidemiology, and end results program: a national resource.
Hankey BF; Ries LA; Edwards BK
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1117-21. PubMed ID: 10613347
[No Abstract] [Full Text] [Related]
31. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
32. Does uncle Sam really want you? A response to "Rethinking research Ethics" by Rosamond Rhodes (AJOB 5:1).
Trachtman H
Am J Bioeth; 2005; 5(1):W22-3. PubMed ID: 16036645
[No Abstract] [Full Text] [Related]
33. Breast cancer risk and hormone replacement therapy: a review of the epidemiology.
Hunt K
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():67-74. PubMed ID: 7874189
[TBL] [Abstract][Full Text] [Related]
34. Cancer surveillance during HRT.
Palacios S
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
[TBL] [Abstract][Full Text] [Related]
35. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
[No Abstract] [Full Text] [Related]
36. Hormone replacement therapy, breast and endometrial cancer.
La Vecchia C
Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
[No Abstract] [Full Text] [Related]
37. Estrogen therapy and breast cancer.
Gambrell RD
Int J Fertil; 1990; 35(4):202-4. PubMed ID: 1977710
[No Abstract] [Full Text] [Related]
38. Re: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
Tuttle TM; Habermann EB; Virnig B
J Natl Cancer Inst; 2010 Sep; 102(17):1371-2; author reply 1372-3. PubMed ID: 20705935
[No Abstract] [Full Text] [Related]
39. Tissues from population-based cancer registries: a novel approach to increasing research potential.
Goodman MT; Hernandez BY; Hewitt S; Lynch CF; Coté TR; Frierson HF; Moskaluk CA; Killeen JL; Cozen W; Key CR; Clegg L; Reichman M; Hankey BF; Edwards B
Hum Pathol; 2005 Jul; 36(7):812-20. PubMed ID: 16084952
[TBL] [Abstract][Full Text] [Related]
40. Limitations and biases of the Surveillance, Epidemiology, and End Results database.
Park HS; Lloyd S; Decker RH; Wilson LD; Yu JB
Curr Probl Cancer; 2012; 36(4):216-24. PubMed ID: 22481009
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
